QUEBEC CITY, Aug. 8, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the "Company") will announce its second quarter 2012
financial and operating results after market close on Tuesday, August
14, 2012. The Company will host a conference call on the following day,
Wednesday, August 15, 2012, at 8:30 a.m. (Eastern Time), to discuss
these results, provide an update on the Company's business and discuss
expectations for the future.
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers:
in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.
A replay of the webcast will also be available on the Company's website
for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company's pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information, please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.